At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Jul 16, 2026 at 17:20 ET
Three PTC Therapeutics insiders, including the CFO and Chief Technical Ops Officer, sold a total of $1.40M in stock over a one-week window. The sales are modest relative to the $6.5B market cap (0.02%) and are likely driven by routine portfolio diversification or tax planning, not a bearish signal on fundamentals.
- Three insiders sold shares totaling $1.40M between July 7-14, 2026.
- CFO Pierre Gravier sold 3,494 shares at $80.35 for $280,743.
- Chief Technical Ops Officer Neil Almstead sold 2,500 shares at $90.25 for $222,000.
- Director Mary L. Smith sold 10,000 shares at $90.00 for $900,000.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access